-+ 0.00%
-+ 0.00%
-+ 0.00%

Dianthus Therapeutics shareholders elect Class II directors at annual meeting

PUBT·05/22/2026 20:11:24
Listen to the news
Dianthus Therapeutics shareholders elect Class II directors at annual meeting
  • Dianthus Therapeutics held its annual shareholder meeting on May 21, 2026.
  • Shareholders backed the board’s slate for Class II directors, with terms running through the 2029 annual meeting.
  • An advisory resolution on executive compensation passed.
  • Shareholders ratified Deloitte & Touche as independent registered public accounting firm for the fiscal year ending Dec. 31, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dianthus Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001690585-26-000026), on May 22, 2026, and is solely responsible for the information contained therein.